Stay updated on Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Sign up to get notified when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.

Latest updates to the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedA sitewide NIH notice says agencies are transitioning from the term “artificial intelligence” to “super intelligence” and links to updates and FAQs.SummaryDifference0.6%

- Check21 days agoChange DetectedThe ClinicalTrials.gov footer revision was updated from v3.7.1 to v3.7.2. This reflects a site release identifier change rather than an update to the clinical study record.SummaryDifference0.1%

- Check28 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check49 days agoChange DetectedThe study record history now includes a new entry for Revision: v3.7.0, replacing the previous Revision: v3.6.6 in the version history.SummaryDifference0.1%

- Check70 days agoChange DetectedThe record history now includes a new revision entry (v3.6.6) replacing the previous revision (v3.6.5), indicating an updated page version.SummaryDifference0.1%

Stay in the know with updates to Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.